top of page


£49 (84 capsules)

weight management medication


Orlistat is indicated for weight loss in patients in conjunction with a mildly hypocaloric diet.

About the Service:

Objectives of treatment

This treatment is used to reduce the Body Mass Index (BMI) in obese patients (BMI 30+) or in overweight patients (BMI of 27-30) with one or more weight-related co-morbidities.

Who is this treatment available to?

  • Patients between 18 and 65 years of age.

  • Patients with an initial BMI of 30 and over.

  • Patients in which a supervised diet, behaviour modification and increasing physical activity failed to achieve a realistic reduction in weight.

  • Patients with a BMI 28 or greater with associated risk factors, including but not limited to: Hypertension; Dyslipidaemia; Obstructive sleep apnoea; Type 2 diabetes mellitus

This treatment is only available ages between 18 and 65 years.

Furthermore, Any Cancellation within 48 hours prior to appointment will incur a charge of 20% of total service cost.

bottom of page